Latest News

PHARMAC widens access to funded treatments for multiple sclerosis

February 12, 2021 | Advocacy, Life with MS, Treatments

Media Release – 12 February 2021 – Released by PHARMAC PHARMAC announced today that it will be widening access to all funded multiple sclerosis treatments from 1 March. 1800 people with multiple sclerosis will be able to stay on their […]


Media Release – PHARMAC widens access to funded treatments for multiple sclerosis

February 12, 2021 | Advocacy, Life with MS, Treatments

(Pharmac Media Release – 12 February 2021) PHARMAC announced today that it will be widening access to all funded multiple sclerosis treatments from 1 March. 1800 people with multiple sclerosis will be able to stay on their treatment for longer, […]


Covid-19 in Ocrelizumab-treated people with Multiple Sclerosis

January 26, 2021 | Covid-19, Life with MS, Research, Treatments

This article, written by the Journal of Multiple Sclerosis and related disorders,  (MSARD) includes data from clinical trials, post marketing safety surveillance and a US electronic medical records database, Optum. The objective was to better understand the SARS-CoV-2 infection in […]


Public Consultation Meeting on Proposed Changes to MS Treatments

December 4, 2020 | Advocacy, Life with MS, Treatments

On Friday 27th November 2020, Pharmac released public consultation on a proposal to widen access to funded multiple sclerosis treatments and transition access from the Multiple Sclerosis Treatment Assessment Committee (MSTAC) Panel to a standard Special Authority. Consultation closes 4pm […]


No More Dreaded 500 Metre ‘Walk of Shame’ For Kiwis With MS?

November 27, 2020 | Advocacy, Life with MS, Treatments

Media Release No More Dreaded 500 Metre ‘Walk of Shame’ For Kiwis With MS? A six year battle to allow multiple sclerosis patients continued access to vital funded drug treatments may soon be over, with news that Pharmac is finally […]